Fatigue Assessment Scales: A comprehensive literature review

Aghdam, sahar Rahimian; Alizadeh, Seyed Shamseddin; Rasoulzadeh, Yahya; Safaiyan, Abdolrasoul

doi:10.29252/archhygsci.8.3.145

Cited by 18 publications

(13 citation statements)

References 32 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Examples of widely used multidimensional scales include the Piper Fatigue Scale (Piper et al, 1989), the Multidimensional Fatigue Symptom Inventory (Stein et al, 2004), and the Multidimensional Fatigue Inventory-20 (Smets et al, 1995). Unidimensional fatigue scales measure fatigue severity only and, as a result of their brevity, are well suited to clinical settings (Aghdam et al, 2019). In contrast, multidimensional scales measure various aspects of fatigue, addressing not only fatigue severity but also the impact of fatigue on physical function and socio-affective functions.…”

Section: Introductionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Psychometric Evaluation of the Korean Version of the Functional Assessment of Chronic Illness Therapy-Fatigue

Lee

Kim

2022

Journal of Nursing Research

View full text Add to dashboard Cite

Cancer is a prevalent disease worldwide. According to a report by the Organization for Economic Cooperation and Development (2021), the average incidence rate of cancer is 294 per 100,000 population, and cancer is the second most common cause of death in Organization for Economic Cooperation and Development member countries. The incidence rate in Korea is also high at 243 per 100,000, with cancer ranking as the most prominent cause of death in the country (27.0%; Statistics Korea, 2021).Fatigue is one of the most commonly occurring subjective symptom in patients with cancer (Berger et al., 2020) and may be associated with either the cancer itself or related treatments and often does not improve with rest (Cella et al., 2002). Severe fatigue has been shown to impair physical function, reduce quality of life, delay treatment, and increase mortality (Mai et al., 2019). Thus, accurate and efficient fatigue assessment is essential for the successful completion of cancer treatment and improvement of survival rates in patients with cancer.Fatigue in patients with cancer is often assessed using selfreport questionnaires that employ either a unidimensional scale or a multidimensional scale. Examples of questionnaires featuring unidimensional scales include the Profile of Mood States Fatigue (McNair et al., 1992), the Brief Fatigue Inventory (Mendoza et al., 1999), and the Fatigue Severity Scale (Krupp et al., 1989). Examples of widely used multidimensional scales include the Piper Fatigue Scale (Piper et al., 1989), the Multidimensional Fatigue Symptom Inventory (Stein et al., 2004), and the Multidimensional Fatigue Inventory-20 (Smets et al., 1995). Unidimensional fatigue scales measure fatigue severity only and, as a result of their brevity, are well suited to clinical settings (Aghdam et al., 2019

show abstract

Section: Introductionmentioning

confidence: 99%

mentioning

confidence: 99%

Psychometric Evaluation of the Korean Version of the Functional Assessment of Chronic Illness Therapy-Fatigue

Lee

Kim

2022

Journal of Nursing Research

View full text Add to dashboard Cite

show abstract

“…The minimum to maximum total score is 0-33 for each person, with the higher scores indicating higher severity of fatigue. The validity and reliability of CFQ have been confirmed in several studies carried out on the general population, patients and Iranians (Rahimian Aghdam et al, 2019;Jackson, 2015).…”

Section: Outcome Assessmentsmentioning

confidence: 74%

Green tea might be effective in alleviating COVID-19 associated psychiatric complications: preliminary results from a pilot randomized controlled trial

Mahdavi-Roshan

Salari

Mohammadyari

et al. 2021

NFS

View full text Add to dashboard Cite

Purpose It is argued that COVID-19 patients show various neuropsychiatric symptoms, including fatigue, depression and anxiety. On the other hand, epidemiological and experimental evidence indicated that green tea could potentially have antiviral effects and ameliorate psychiatric disorders. However, there is a lack of clinical evidence. The purpose of this study was to investigate whether drinking green tea can clinically improve psychiatric complications of COVID-19 infection. Design/methodology/approach This study included 40 patients with laboratory confirmed mild-to-moderate COVID-19 disorder in the current randomized open-label controlled trial. Patients were instructed to include three cups/day of green tea (intervention) or black tea (control) to their usual diet for four weeks immediately after diagnosis of the disease. At the study baseline and after the intervention, the enrolled patients’ fatigue, depression and anxiety were assessed by the Chalder Fatigue Scale, Beck Depression Inventory-Fast Screen and State-Trait Anxiety Inventory questionnaires. Findings A total of 19 COVID-19 cases in the intervention group (mean age = 52 years) and 14 cases (mean age = 50 years) in the control group completed the study. Analysis of covariance adjusted for baseline levels, and confounders revealed that those who consumed three cups/day of green tea compared to the patients who received black tea experienced significantly lower fatigue, depression and state and trait anxiety levels (adjusted means for fatigue = 12.3 vs 16.2 (P = 0.03), depression = 0.53 vs 1.8 (P = 0.01), 37.4 vs 45.5 (P < 0.01) and 37.9 vs 45.2 (P < 0.01)). Research limitations/implications The open-label design may bias the evaluation of the self-reported status of fatigue, depression or anxiety as the main outcomes assessed. Moreover, as this study did not include patients with severe COVID-19, this might affect the generalizability of the present results. Thus, the recommendation of daily drinking green tea may be limited to the subjects diagnosed with mild-to-moderate type of infection or those with long-term neuropsychiatric complications owing to COVID-19. Besides, considering the ethical issues, this study could not exclude the drug therapy’s confounding effects; thereby, this point should be considered when interpreting the current results. Besides, it is worth noting that Guilan province in the north of Iran is recognized as a tea (and particularly green tea) producing region; thereby, it is an available and relatively inexpensive product. Considering this issue, the recommendation to consume this medicinal plant in adjunct to the routine treatment approach among patients with mild-to-moderate COVID-19 based on its beneficial effects may be widely accepted. Practical implications Green tea consumption could be considered an option to combat COVID-19 associated psychological complications, including fatigue, depression and anxiety among patients suffering from mild-to-moderate type of this viral infection. Originality/value To the best of the authors’ knowledge, in this study, for the first time, the effects of green tea compared to black tea on COVID-19 associated fatigue, depression and anxiety status within an open-label controlled trial have been investigated.

show abstract

“…Jawaban pertanyaan terbagi menjadi 5 skala likert, yaitu tidak pernah (1), kadang-kadang (2), umumnya (3), sering (4), dan selalu (5) (Aghdam et al, 2019). Pekerja dikategorikan normal (tidak lelah) apabila memperoleh skor 10 sampai 21, apabila skor lebih dari 21 (>21) maka pekerja tersebut dikategorikan lelah.…”

Section: Materials Dan Metodeunclassified

Effect of Daily Trip System on Pt. X Contractor Worker Fatigue at Offshore Site

Nuraini

Ramdhan

2021

J Vocat Heal Stud

View full text Add to dashboard Cite

Background: PT. X implements a daily trip method that takes ±1,5 hours to arrive at the offshore platforms. Travel time that’s too long can cause fatigue. Purpose: Analyzing the effect of a daily trip system on PT. X contractor worker fatigue at offshore site. Method: This research was conducted at one of PT. X’s offshore Gresik Sites in June 2021 used Fatigue Assessment Scale (FAS) questionnaire with observational analytics method and cross-sectional study design. Research samples were taken from the population of 153 construction workers PT. X at offshore site. The data obtained were analyzed using quantitative approach, data analysis used univariate analysis and bivariate analysis, chi-square statistical test with significance value or confidence interval was 95% and error interval was 5% (CI = 95% and α = 0.05). Result: PT. X Contractor workers at the offshore site had 85 workers (55.56%) that get fatigue. Statistical analysis test showed there was no significant relationship between a daily trip system with fatigue on PT. X Contractor workers at the offshore site (p-value = 0.140). Factors that affect fatigue on PT. X Contractor workers at the offshore site were age, body mass index, and workload (p-value successive were 0.047, 0.014, and 0.001). Conclusion: A daily trip system has no effect with fatigue on PT. X contractor worker at the offshore site, recommended for the contractor to improve the BMI and manage the workload so that its more evenly distributed.

show abstract

Fatigue Assessment Scales: A comprehensive literature review

Cited by 18 publications

References 32 publications

Psychometric Evaluation of the Korean Version of the Functional Assessment of Chronic Illness Therapy-Fatigue

Psychometric Evaluation of the Korean Version of the Functional Assessment of Chronic Illness Therapy-Fatigue

Green tea might be effective in alleviating COVID-19 associated psychiatric complications: preliminary results from a pilot randomized controlled trial

Effect of Daily Trip System on Pt. X Contractor Worker Fatigue at Offshore Site

Contact Info

Product

Resources

About